tiprankstipranks
pc:yolte

YolTech Therapeutics

YolTech Therapeutics is a clinical-stage biotechnology company focused on developing next-generation in vivo gene-editing therapies for one-time treatment. Founded in 2021, the company has established a comprehensive platform featuring proprietary CRISPR nucleases, base editors, and a lipid nanoparticle delivery system to enable precise and efficient gene editing. YolTech's clinical pipeline includes programs targeting transthyretin amyloidosis, familial hypercholesterolemia, primary hyperoxaluria type 1, and β-thalassemia/sickle cell disease. The company operates a cGMP-compliant manufacturing facility to support clinical supply and early commercial scale-up.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$45M
Total Amount Raised$45M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$45M
Latest Funding Amount$45M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 11, 2025
Series B
$45.00M

Investors

Investor Name
Funding Round

Related News and Analysis